Study details
Enrolling now
Endovascular Exclusion of Thoracoabdominal And/or Paravisceral Abdominal Aortic Aneurysm
Warren J. Gasper, MD
NCT IDNCT00483249ClinicalTrials.gov data as of Apr 2026
Target enrollment
250
Study length
about 22 years
Ages
18+
Locations
2 sites in CA
What this study is about
This trial is testing a new way to treat thoracoabdominal and paravisceral abdominal aortic aneurysms using an endovascular stent-graft. The goal is to determine the safety and effectiveness of this treatment approach.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Endovascular Branched Stent-Graft
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Devices
implantable